Charlotte's Web Holdings, Inc. (CWBHF) Charlotte's Web Holdings, Inc. specializes in the cultivation, manufacturing, marketing, and distribution of hemp-derived cannabidiol (CBD) wellness products. Their extensive product range includes liquid hemp extract tinctures, various gummies (designed for sleep, stress relief, immune support, and exercise recovery), capsules, topical CBD creams and lotions, and specific offerings for pets. These are sold under prominent brands such as Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids like CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), along with terpenes, flavonoids, and a spectrum of other beneficial hemp compounds. The company reaches its customers through multiple channels, including traditional retail outlets, health care practitioners, and direct-to-consumer sales via its official website. Charlotte's Web actively advances hemp cannabinoid science through key collaborations. Its CW Labs division works with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 and headquartered in Denver, Colorado, the company was formerly known as Stanley Brothers Holdings Inc. before officially changing its name to Charlotte's Web Holdings, Inc. in July 2018.
Sector: Agricultural Production-Crops
Industry: Drug Manufacturers - Specialty & Generic
Charlotte's Web Holdings, Inc. OTC:CWBHF Healthcare · Drug Manufacturers - Specialty & Generic
All Press Release SEC Filings News
Press Release
Charlotte's Web Applauds Congressional Action to Advance Continuing Resolution
newsfilecorp.com • 1mo ago Press Release
Charlotte's Web and Edibles.com Team up to Protect Consumer Access and Shape Hemp's Future
newsfilecorp.com • 2mo ago SEC Filing ⚠ 4
CWBHF: 8-K · material agreement
Charlotte's Web's wholly-owned subsidiary issued a $1,582,500 convertible promissory note to DeFloria, Inc. effective August 14, 2026, incorporating and superseding a prior July 2025 note that carried $750,000 in original principal plus $82,500 of accrued interest.
The unsecured note bears an initial interest rate of 11.25% per annum, calculated as 8.0% plus the Bank of England Base Rate with quarterly resets and a 14% cap, and matures on demand by majority noteholders only after the 24-month anniversary of the most recent note issuance under the February 2024 purchase agreement.
The note converts automatically if DeFloria raises at least $10,000,000 from non-affiliated investors, at the lesser of an 80% discount to the financing price or a price implied by a $146,000,000 valuation cap, and requires accelerated repayment with a 20% premium in a deemed liquidation event unless Charlotte's Web elects to convert into DeFloria senior preferred stock.
DeFloria is a joint venture among Charlotte's Web, AJNA BioSciences, and a subsidiary of British American Tobacco, so the filing signals continued incremental funding of the BAT-backed JV rather than a change in the company's core strategy.
SEC 8-K • 2mo ago AI analysis › Press Release
Charlotte's Web Launches Route CBD to Support Californians Who Depend on Full-Spectrum Hemp CBD
newsfilecorp.com • 2mo ago SEC Filing ⚠ 6
CWBHF: 10-Q · periodic report
Charlotte's Web Holdings filed its Form 10-Q for the quarter ended June 30, 2026, reporting revenue of $10.9 million, down 15.2% year over year, driven by its shift of most retail business to a more margin-accretive distributor model in the third quarter of 2025. Second-quarter net loss narrowed to $4.1 million ($0.02 per share) from $6.3 million a year earlier, though the first-half loss widened to $17.2 million including a one-time debt charge.
The quarter's defining event was the May 28, 2026 transaction with BT DE Investments, a subsidiary of British American Tobacco: the C$75.3 million convertible debenture plus C$14.2 million of accrued interest was converted into 95,281,277 shares at C$0.94, and BT DE separately purchased 14,662,765 shares for $10 million. BAT now holds approximately 40.6% of Charlotte's Web common shares, and the company recognized a $4.2 million loss on extinguishment of debt.
The balance sheet improved materially: cash rose to $14.0 million from $8.0 million at year-end 2025, total liabilities fell to $20.3 million from $73.0 million, and first-half operating cash burn narrowed to $3.7 million from $6.8 million. Management stated existing cash is sufficient to fund operations for the next 12 months, leaving shrinking revenue and continued losses as the key open questions.
SEC 10-Q • 2mo ago AI analysis › SEC Filing ⚠ 6
CWBHF: 8-K · earnings release
Charlotte's Web Holdings reported second quarter 2026 revenue of $10.9 million, down 15.2% from $12.8 million a year earlier, reflecting the retail channel restructuring it initiated in September 2025. Net loss narrowed to $4.1 million, or $(0.02) per share, from $6.3 million, or $(0.04) per share, and Adjusted EBITDA improved to a loss of $3.0 million from $3.6 million.
The quarter's defining event was the May 28, 2026 recapitalization with BT DE Investments Inc., a subsidiary of British American Tobacco: BAT's C$75.3 million convertible debenture converted to equity at C$0.94 per share, eliminating the $50.8 million debenture and cutting total liabilities 74%, or $57.0 million. A concurrent $10 million BAT private placement lifted cash to $14.0 million and restored shareholders' equity to $56.1 million from a $2.0 million deficit.
Operationally, gross margin expanded to 47.5% from 46.8%, SG&A declined 5.4% to $9.5 million, and second quarter operating cash use fell to $0.9 million from $2.8 million in the first quarter. The share count rose roughly 70% to 270,549,931 shares as a result of the conversion and placement.
Federal hemp policy turned favorable, with the Senate passing a continuing resolution that postpones the Section 781 hemp product ban to December 11, 2026, and bipartisan hemp legislation pending, while California restrictions still affect roughly 10% of revenue. The company is also advancing DeFloria's AJA001 botanical drug candidate, in which it owns about one-third, toward a Phase 2 trial in autism-related irritability.
SEC 8-K • 2mo ago AI analysis › Press Release ● Major
Charlotte's Web Reports Second Quarter 2026 Financial Results
newsfilecorp.com • 2mo ago Press Release
Charlotte's Web Welcomes Senate Passage of Hemp Extension Marking Important Progress Toward a Long-Term Federal Hemp Framework
newsfilecorp.com • 2mo ago Press Release
Charlotte's Web Provides Update on Diverging Hemp Policies: Federal Momentum Builds as California Restricts Therapeutic Hemp Product Access
newsfilecorp.com • 4mo ago Press Release ● Major
Charlotte's Web Announces Board Transition as Co-Founder Jared Stanley Deepens Focus on DeFloria
newsfilecorp.com • 4mo ago Press Release ● Major
Charlotte's Web Appoints Jeff Raborn to Board of Directors
newsfilecorp.com • 4mo ago SEC Filing ● Major ⚠ 4
CWBHF: 8-K · acquisition merger
Charlotte's Web Holdings, Inc. announced the closing of a transformative transaction with British American Tobacco (BAT), converting approximately $65 million of outstanding debt into equity and securing a concurrent $10 million cash investment. The deal results in the issuance of roughly 110 million new shares to BAT, giving the tobacco giant a 40.6% ownership stake and establishing it as a 'Control Person' under Canadian securities laws.
The transaction significantly strengthens Charlotte's Web's balance sheet by eliminating the convertible debenture and injecting fresh liquidity. Management stated the proceeds will support participation in the anticipated CMMI Medicare pilot program and other medical channel initiatives, aiming to expand access to CBD products for eligible beneficiaries.
In related governance matters, shareholders approved the election of six directors, including James Jeffery Raborn, a BAT designee, to the board. The annual meeting also ratified the appointment of PKF O’Connor Davies LLP as auditors and approved the amendment to the investor rights agreement with BAT.
SEC 8-K • 4mo ago AI analysis › Press Release ● Critical
Charlotte's Web Announces Closing of Transaction with British American Tobacco, Including US$10 Million Investment
newsfilecorp.com • 4mo ago Press Release
Charlotte's Web Reports Shareholder Meeting Voting Results
newsfilecorp.com • 4mo ago SEC Filing ⚠ 3
CWBHF: 8-K · earnings release
Charlotte’s Web Holdings, Inc. reported a revenue of $11.2 million for the first quarter of 2026, a 9.0% decrease from $12.3 million in the same period of 2025. This decline is primarily due to the Company's decision to exit lower-margin retail relationships in September 2025, which is expected to improve the quality of the product and channel mix.
The Company's net loss for Q1 2026 was $13.1 million, or $(0.08) per share, compared to a net loss of $6.2 million, or $(0.04) per share, in Q1 2025. The Q1 2026 net loss includes a non-cash charge of $8.9 million related to the change in fair value of financial instruments, primarily the mark-to-market adjustment on the BAT convertible debenture derivative liability.
Charlotte’s Web announced a proposed transaction with BT DE Investments Inc., a subsidiary of British American Tobacco, to convert BAT’s outstanding convertible debenture of approximately $54 million and complete a $10 million private placement. Upon completion, BAT would hold approximately 40% of the Company’s shares, and the transaction would eliminate the Company's largest balance sheet liability and remove approximately $3 million in annual interest costs.
The Company has also qualified for trading on the OTCQX Best Market, an upgrade from the OTCQB Venture Market, which is expected to enhance visibility and accessibility for U.S. investors.
SEC 8-K • 5mo ago AI analysis › Press Release ● Major
Charlotte's Web First Quarter 2026 Financial Results
newsfilecorp.com • 5mo ago Press Release
CURED Nutrition Joins One Hemp, Strengthening Industry Alignment Ahead of Key Federal Legislative Deadline
newsfilecorp.com • 6mo ago 
